Sale!

SFTPA1 Gene Pulmonary fibrosis idiopathic Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SFTPA1 gene plays a crucial role in lung health, encoding a protein essential for maintaining the surface tension within the alveoli and for protecting the lungs from inhaled microbes and environmental toxins. Mutations in the SFTPA1 gene have been associated with an increased risk of developing idiopathic pulmonary fibrosis (IPF), a chronic, progressive lung disease characterized by the thickening and scarring (fibrosis) of lung tissue, which significantly impairs breathing and oxygen transfer.

Recognizing the genetic component in the susceptibility to IPF, DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the SFTPA1 gene. This test is an invaluable tool for individuals with a family history of pulmonary fibrosis or for those presenting symptoms of the disease, providing them with crucial information regarding their risk and aiding in the early detection and management of the condition.

The test is priced at 4400 AED, reflecting the comprehensive analysis and personalized interpretation of results it entails. Conducted in state-of-the-art facilities by a team of expert geneticists and clinicians, the SFTPA1 gene test is a significant step forward in the personalized approach to the diagnosis and management of idiopathic pulmonary fibrosis, offering patients and their families the information necessary to navigate this challenging condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SFTPA1 Gene Pulmonary Fibrosis Idiopathic Genetic Test

Are you or a loved one experiencing symptoms of pulmonary fibrosis? DNA Labs UAE offers a comprehensive genetic test to analyze the SFTPA1 gene and other genes associated with this condition. Read on to learn more about the test details, cost, symptoms, and diagnosis process.

Test Name: SFTPA1 Gene Pulmonary Fibrosis Idiopathic Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information

Prior to undergoing the SFTPA1 Gene Pulmonary Fibrosis Idiopathic Genetic Test, it is important to provide a clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the SFTPA1 gene.

Test Details

The SFTPA1 gene is associated with pulmonary fibrosis, a lung disease characterized by the formation of scar tissue in the lungs. This condition can be caused by various factors, including genetic mutations. Our NGS genetic testing method allows for the simultaneous analysis of multiple genes, providing a comprehensive evaluation of an individual’s genetic makeup.

Idiopathic pulmonary fibrosis (IPF) refers to cases where the cause of the disease is unknown. NGS genetic testing can help identify genetic mutations, including those in the SFTPA1 gene, that may contribute to the development of IPF. By identifying specific genetic mutations, this test can assist in diagnosing pulmonary fibrosis, predicting disease progression, and guiding personalized treatment plans.

Furthermore, NGS genetic testing can identify individuals who may be at risk of developing pulmonary fibrosis, enabling early intervention and monitoring. It is important to note that genetic testing for pulmonary fibrosis is typically performed alongside other diagnostic tests, such as imaging studies and pulmonary function tests, to provide a comprehensive evaluation of the condition.

Genetic counseling is highly recommended both before and after genetic testing. This counseling session will help individuals understand the implications of the test results and make informed decisions about their healthcare.

If you or a loved one are experiencing symptoms of pulmonary fibrosis, consider undergoing the SFTPA1 Gene Pulmonary Fibrosis Idiopathic Genetic Test at DNA Labs UAE. Early detection and personalized treatment plans can greatly improve the management of this condition.

Test Name SFTPA1 Gene Pulmonary fibrosis idiopathic Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SFTPA1 Gene Pulmonary fibrosis, idiopathic NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SFTPA1 Gene Pulmonary fibrosis, idiopathic NGS Genetic DNA Test gene SFTPA1
Test Details

The SFTPA1 gene is associated with pulmonary fibrosis, which is a lung disease characterized by the formation of scar tissue in the lungs. Pulmonary fibrosis can be caused by various factors, including genetic mutations.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive evaluation of an individual’s genetic makeup. In the case of pulmonary fibrosis, NGS genetic testing can be used to identify mutations in the SFTPA1 gene and other genes associated with the condition.

Idiopathic pulmonary fibrosis (IPF) refers to cases where the cause of the disease is unknown. NGS genetic testing can help identify genetic mutations that may contribute to the development of IPF, including mutations in the SFTPA1 gene.

By identifying specific genetic mutations, NGS genetic testing can provide valuable information for diagnosing pulmonary fibrosis, predicting disease progression, and guiding personalized treatment plans. It can also help identify individuals who may be at risk of developing the condition, allowing for early intervention and monitoring.

It is important to note that genetic testing for pulmonary fibrosis is typically performed in conjunction with other diagnostic tests, such as imaging studies and pulmonary function tests, to provide a comprehensive evaluation of the condition. Genetic counseling is often recommended before and after genetic testing to help individuals understand the implications of the test results and make informed decisions about their healthcare.